Humacyte (HUMA) Faces Questions After FDA Inspection Hagens Berman

Globe NewswireOct 25 02:55

Humacyte to Host Virtual KOL Event on the Use of Acellular Tissue Engineered Vessel (ATEV) for AV Access in Hemodialysis on October 31, 2024

GlobeNewswireOct 23 20:00

BTIG Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 18 21:31 · Ratings

Piper Sandler Maintains Humacyte(HUMA.US) With Hold Rating, Raises Target Price to $6

Futu NewsOct 18 19:35 · Ratings

Piper Sandler Sticks to Its Hold Rating for Humacyte (HUMA)

TipRanksOct 18 18:36 · Ratings

12 Health Care Stocks Moving In Thursday's After-Market Session

BenzingaOct 18 04:30